Clinical Trial Search

Primary: Rates of Good/Excellent Cosmesis as Measured by the Radiation Therapy Oncology Group (RTOG) Cosmetic Rating Scale - Rated by Physician — 45 Participants

Primary: Number of Participants With Engraftment. — 18; 12 participants

Primary: Remission of Depressive Symptoms — 14; 14 participants

Primary: IL-8 Concentrations — 12,795; 14,676 Pg/ml — p=0.6

Primary: Subject Perception of Pain and Anxiety During Uterine Aspiration — 74.3; 70.1; 68.2; 60.9 mm

Primary: Number of Participants With Clinical Response — 43; 63 Participants

Primary: Overall Morbidity — 0; 0; 0; 0 Participants

Primary: Part 1: Percentage of Participants With Plasma HIV-1 RNA Decreases From Baseline Exceeding 0.5 log10 at Day 10 — 58.3; 60.7; 0 percentage of participants — p=<0.001

Primary: Number and Percentage of Patients/Caregivers Who Successfully Administered Benralizumab 30 mg Subcutaneously (SC) by Injection With an APFS at Home — 112; 108; 106…

Primary: Change From Baseline in Evening (Post Meridiem [PM]) Forced Expiratory Volume in One Second (FEV1) Using Intent-to-Treat (ITT) Population — 0.019; 0.000; -0.104 Liter…

Primary: The Primary Efficacy Variable Was the AAC for Daily EXACT Scores During the 12-week Treatment Period. — 415.4; 391.7 Area Above Curve on Daily Exact Score — p=0.759

Primary: Endpoint Hamilton Depression Rating Scale (HAMD) Scores Adjusted for Age, Sex, Treatment Site, and Baseline HAMD Scores. — 15.1; 15.7; 14.9 units on a scale — p=0.74

Primary: Number of Subjects With a Primary Event of Respiratory Death, First COPD-Related Emergency Room Visit, or First COPD Exacerbation-Related Hospitalisation — 64; 57…

Primary: Cumulative CD54 Upregulation Ratio Between the Cohorts. — 36.72; 41.61 Ratio ofCD54 molecules on BDS65:FP cells — p=0.2141

Primary: The Rate of Moderate and Severe COPD Exacerbations Defined as: Worsening of ≥2 Major Symptoms or Worsening of 1 Major Symptom Together With ≥1 Minor Symptom for ≥2…